These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28722190)

  • 1. Estimating population effects of vaccination using large, routinely collected data.
    Halloran ME; Hudgens MG
    Stat Med; 2018 Jan; 37(2):294-301. PubMed ID: 28722190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the second European expert meeting on rotavirus vaccination.
    Giaquinto C; Jackson AE; Vesikari T
    Vaccine; 2012 Mar; 30(13):2237-44. PubMed ID: 22178724
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning to Trust Flu Shots: Quasi-Experimental Evidence from the 2009 Swine Flu Pandemic.
    Maurer J; Harris KM
    Health Econ; 2016 Sep; 25(9):1148-62. PubMed ID: 27381724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons.
    Lu PJ; Santibanez TA; Williams WW; Zhang J; Ding H; Bryan L; O'Halloran A; Greby SM; Bridges CB; Graitcer SB; Kennedy ED; Lindley MC; Ahluwalia IB; LaVail K; Pabst LJ; Harris L; Vogt T; Town M; Singleton JA;
    MMWR Surveill Summ; 2013 Oct; 62(4):1-28. PubMed ID: 24157710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
    Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
    Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the 'European Expert Meeting on Rotavirus Vaccination', Tampere, Finland, 19-20 May 2009.
    Vesikari T; Sutherland D; Jackson AE
    Vaccine; 2009 Dec; 27(52):7222-7. PubMed ID: 19822233
    [No Abstract]   [Full Text] [Related]  

  • 10. A mathematical model of the indirect effects of rotavirus vaccination.
    Van Effelterre T; Soriano-Gabarró M; Debrus S; Claire Newbern E; Gray J
    Epidemiol Infect; 2010 Jun; 138(6):884-97. PubMed ID: 20028612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity.
    Matsuoka T; Sato T; Akita T; Yanagida J; Ohge H; Kuwabara M; Tanaka J
    Int J Environ Res Public Health; 2016 Oct; 13(10):. PubMed ID: 27763532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccination in older people with diabetes and their household contacts.
    Yang L; Nan H; Liang J; Chan YH; Chan L; Sum RW; Kwan YM; Zhou F; Meng H; Suen LK
    Vaccine; 2017 Feb; 35(6):889-896. PubMed ID: 28094076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccination: short-term indirect herd protection, long-term uncertainty.
    Yi J; Anderson EJ
    Expert Rev Vaccines; 2013 Jun; 12(6):585-7. PubMed ID: 23750788
    [No Abstract]   [Full Text] [Related]  

  • 14. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
    BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing herd immunity with influenza revaccination.
    Mooring EQ; Bansal S
    Epidemiol Infect; 2016 Apr; 144(6):1267-77. PubMed ID: 26482721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the herd immunity effect of rotavirus vaccine.
    Pollard SL; Malpica-Llanos T; Friberg IK; Fischer-Walker C; Ashraf S; Walker N
    Vaccine; 2015 Jul; 33(32):3795-800. PubMed ID: 26116250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy.
    Tharmaphornpilas P; Jiamsiri S; Boonchaiya S; Rochanathimoke O; Thinyounyong W; Tuntiwitayapun S; Guntapong R; Riewpaiboon A; Rasdjarmrearnsook AO; Glass RI
    Vaccine; 2017 Feb; 35(5):796-801. PubMed ID: 28057385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect protection and indirect measures of protection from rotavirus in adults.
    Anderson EJ; Reddy S; Katz BZ; Noskin GA
    J Infect Dis; 2012 Jun; 205(11):1762-4; author reply 1764-5. PubMed ID: 22457285
    [No Abstract]   [Full Text] [Related]  

  • 20. Rotavirus Infection: A Disease of the Past?
    Dennehy PH
    Infect Dis Clin North Am; 2015 Dec; 29(4):617-35. PubMed ID: 26337738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.